|
Market Cap (5-Jun) $61,568,592 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (26-May) 11,577 (0.00%) (629th) |
|
52w High $0.425 |
52w Low $0.056 |
P/E - |
EPS -0.02 |
ATX released this announcement to the ASX on 15 September 2021, 8:59. The announcement is not marked as price sensitive, and is 34 page(s) in length and 2.58MB in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.012% short sold according to ASIC data. It was ranked the 606th most shorted stock on the ASX. It remains ranked 629th as of the latest reported data (26 May 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| Updated Investor Presentation | 15 September 2021, 8:59 |
| Change of Director's Interest Notice - Jane Bell | 6 September 2021, 10:57 |
| Results of Annual General Meeting | 27 August 2021, 15:00 |
| AGM - Chief Executive Officer's Presentatioin | 27 August 2021, 11:39 |
You must be logged in to post a reply.
Amplia Therapeutics 